In Conversation

The industry tends to foster experts and specialists, but the world is changing so rapidly that we need to be able to transfer knowledge relatively quickly…

A CDMO does not really innovate. We leave that task of research to our excellent customers. What we do well is stay on top of manufacturing…

We position ourselves as a pure play, differentiated, fully vertically integrated biosimilars development and manufacturing company that goes global with partners that are regional champions

When you have started two companies, people think that you like risk. In fact, I hate risk and have tried to avoid it my entire life

We have been on a high-speed train, transforming AbbVie into an agile and high-performing organization, capable of launching a series of new treatments across multiple indications

Cell and gene therapies are truly transformative. With CAR-T therapies, we are entrusted to work with a patient’s own living T-cells. That is a huge responsibility…

Some of the advantages [of Singapore] include an excellent educated workforce, the English language, a reliable legal system, and the absence of corruption, to name just…

Middle Eastern customers hold Switzerland and its pharmaceutical industry in high esteem. Manufacturing products in Switzerland also ensures that they are of the highest quality

A concrete example of Pfizer Norway’s value is our pioneering of digital channels and how we utilize these channels to communicate with physicians and the public

We have had a very significant impact on medical innovation throughout our history

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here